Φορτώνει......

Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study

The present study aimed to conduct a prognosis analysis of Taiwanese patients with metastatic gastrointestinal stromal tumors (GISTs), who are resistant to or were unable to tolerate imatinib or sunitinib, and were subsequently treated with regorafenib. The study considered the survival, potential p...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Oncol Lett
Κύριοι συγγραφείς: Hu, Chia-Hsiang, Yeh, Chun-Nan, Chen, Jen-Shi, Tsai, Chun-Yi, Wang, Shang-Yu, Cheng, Chi-Tung, Yeh, Ta-Sen
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: D.A. Spandidos 2020
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400021/
https://ncbi.nlm.nih.gov/pubmed/32782530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11756
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!